These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35887431)

  • 1. Isavuconazole for COVID-19-Associated Invasive Mold Infections.
    Ullah N; Sepulcri C; Mikulska M
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
    Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
    J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19.
    Bertram R; Naumann HT; Bartsch V; Hitzl W; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Nentwich J; John S; Sörgel F; Steinmann J; Höhl R
    Mycoses; 2023 Dec; 66(12):1071-1078. PubMed ID: 37700457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
    Jenks JD; Salzer HJ; Prattes J; Krause R; Buchheidt D; Hoenigl M
    Drug Des Devel Ther; 2018; 12():1033-1044. PubMed ID: 29750016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
    Miller M; Kludjian G; Mohrien K; Morita K
    Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of isavuconazole in the treatment of invasive fungal infections.
    Wilson DT; Dimondi VP; Johnson SW; Jones TM; Drew RH
    Ther Clin Risk Manag; 2016; 12():1197-206. PubMed ID: 27536124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between flucloxacillin and azoles: Is isavuconazole next?
    Van Daele R; Wauters J; Vandenbriele C; Lagrou K; Vos R; Debaveye Y; Spriet I
    Mycoses; 2021 Dec; 64(12):1508-1511. PubMed ID: 34553797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections.
    Donnelley MA; Zhu ES; Thompson GR
    Infect Drug Resist; 2016; 9():79-86. PubMed ID: 27330318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
    Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
    BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.
    Perez L; Corne P; Pasquier G; Konecki C; Sadek M; Le Bihan C; Klouche K; Mathieu O; Reynes J; Cazaubon Y
    J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections.
    Falci DR; Pasqualotto AC
    Infect Drug Resist; 2013 Oct; 6():163-74. PubMed ID: 24187505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
    Shirley M; Scott LJ
    Drugs; 2016 Nov; 76(17):1647-1657. PubMed ID: 27766566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant.
    Dagher H; Hachem R; Chaftari AM; Jiang Y; Ali S; Deeba R; Shah S; Raad I
    J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35050014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Kohno S; Izumikawa K; Takazono T; Miyazaki T; Yoshida M; Kamei K; Ogawa K; Taniguchi S; Akashi K; Tateda K; Mukae H; Miyazaki Y; Okada F; Kanda Y; Kakeya H; Suzuki J; Kimura SI; Kishida M; Matsuda M; Niki Y
    J Infect Chemother; 2023 Feb; 29(2):163-170. PubMed ID: 36307059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study.
    Batista MV; Ussetti MP; Jiang Y; Neofytos D; Cortez AC; Feriani D; Schmidt-Filho J; França-Silva ILA; Raad I; Hachem R
    J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.
    Zurl C; Waller M; Schwameis F; Muhr T; Bauer N; Zollner-Schwetz I; Valentin T; Meinitzer A; Ullrich E; Wunsch S; Hoenigl M; Grinschgl Y; Prattes J; Oulhaj A; Krause R
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32580296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Isavuconazole for the treatment of invasive
    Sivasubramanian G; Chandrasekar PH
    Expert Opin Pharmacother; 2022 Apr; 23(5):543-549. PubMed ID: 35099351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.